ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.6249 ↑ 0.13%
[as on 14 November, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option -5.79% 0.13% -0.03% -0.19% -0.06% 0.56% 21.34%---

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.53% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.47%

Equity

NameSymbol / ISINSectorWeight %QuantityQty change %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.62%150888-
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology7.79%31001-
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.81%17775-
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.70%115755-
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology5.06%130279+17.21%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.59%28861-
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services4.13%96360-
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.62%75614-
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.45%124462-
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.04%36050-
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.98%12453-
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.93%27224-
Wockhardt LimitedWOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology2.76%41176+3.95%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology2.57%3979-
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology2.45%45285+24.46%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology2.21%33277-
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.19%1690-
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.79%63013-
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.73%45474-
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals1.42%60188-3.17%
FDC LimitedFDC (INE258B01022)Pharmaceuticals & Biotechnology1.39%70933-
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.33%22488+8.32%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology1.31%35263-
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services1.21%20150-
SBI Life Insurance Company LimitedSBILIFE (INE123W01016)Insurance1.17%14830-4.98%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.17%13559+48.27%
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology1.12%36258-
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology1.07%33324-
Standard Glass Lining Technology LtdSGLTL (INE0M4D01010)Industrial Manufacturing1.02%133598-
Onesource Specialty Pharma LimitedONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology1.02%12527-
Sagility India LimitedSAGILITY (INE0W2G01015)IT - Services0.97%515685-
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.93%7906-
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies0.93%10779-
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.86%3135-
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.86%9867-
SRF LimitedSRF (INE647A01010)Chemicals & Petrochemicals0.84%6704-10.68%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.82%24784-
Navin Fluorine International LimitedNAVINFLUOR (INE048G01026)Chemicals & Petrochemicals0.72%3509-12.06%
UPL LimitedUPL (INE628A01036)Fertilizers & Agrochemicals0.67%23209-
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.67%44284-
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.63%14449-
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology0.51%60105-
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.47%17159-

Debt

NameRatingWeight %
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV history

DateNAV
14 November, 202517.6249
13 November, 202517.6025
12 November, 202517.6909
11 November, 202517.5797
10 November, 202517.6634
7 November, 202517.6306
6 November, 202517.7050
4 November, 202517.8206
3 November, 202517.8788
31 October, 202517.6717
30 October, 202517.7869
29 October, 202517.8194
28 October, 202517.7569
27 October, 202517.7558
24 October, 202517.8445
23 October, 202517.9556
20 October, 202517.9517
17 October, 202517.8741
16 October, 202517.7908
15 October, 202517.6808
14 October, 202517.6586
13 October, 202517.7620
10 October, 202517.7775
9 October, 202517.5972
8 October, 202517.4341
7 October, 202517.4689
6 October, 202517.4303
3 October, 202517.2630
1 October, 202517.2759
30 September, 202517.0899

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 17.6249 as on 14 November, 2025.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -5.79% as on 14 November, 2025.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 0.56% as on 14 November, 2025.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 21.34% as on 14 November, 2025.